Inferring effects on tumor frequencies and times to observation in the analysis of tumor multiplicity data

Biometrical Journal

Volumn 43, Issue 4, 2001, Pages 447-460

  Kodell, Ralph L ^a,b   Chen, James J ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Biometry and Risk Assessment   (United States)

Author keywords

Chemoprevention; Initiation promotion; Likelihood ratio; Logrank; Negative binomial; Phototoxicity; Skin painting, Weibull

Indexed keywords

ANIMALS; WEIBULL DISTRIBUTION;

CHEMOPREVENTION; INITIATION-PROMOTION; LIKELIHOOD FUNCTIONS; LIKELIHOOD RATIOS; LOGRANK; NEGATIVE BINOMIAL; PHOTO-TOXICITY; SKIN PAINTING, WEIBULL; WEIBULL; WHETHER DIFFERENCES;

TUMORS;

EID: 0035636776     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4036(200108)43:4<447::AID-BIMJ447>3.0.CO;2-J     Document Type: Article

References (24)

1. BAILER, A. J. and PORTIER, C. J., 1988: Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417-431.
2. BULL, R. J. and PEREIRA, M. A., 1982: Development of a short-term testing matrix for estimating relative carcinogenic risk. Journal of the American College of Toxicology 1, 1-16.
3. DINSE, G. E., 1993: Evaluating constraints that allow survival-adjusted incidence analyses in single-sacrifice studies. Biometrics 49, 399-407.
4. DRINKWATER, N. R. and KLOTZ, J. H., 1981: Statistical methods for the analysis of tumor multiplicity data. Cancer Research 41, 113-119.
5. DUNSON, D. B., 2000: Models for papilloma multiplicity and regression: applications to transgenic mouse studies. Applied Statistics 49, 19-30.
6. DUNSON, D. B. and DINSE, G. E., 2000: Distinguishing effects on tumor multiplicity and growth rate in chemoprevention experiments. Biometrics 56, 1068-1075.
7. DUNSON, D. B. and HASEMAN, J. H., 1999: Modeling tumor onset and multiplicity using transition models with latent variables. Biometrics 55, 965-970.
8. FAIRWEATHER, W. R. et al., 1998: Biostatistical methodology in carcinogenicity studies. Drug Information Journal 32, 401-421.
9. FORBES, P. D., URBACH, F., and DAVIES, R. E., 1979: Enhancement of experimental photocarcinogenesis by topical retinoic acid. Cancer Letters 7, 85-90.
10. FORBES, P. D., DAVIES, R. E., SAMBUCO, C. P., and URBACH, F., 1989: Inhibition of ultraviolet radiation-induced skin tumors in hairless mice by topical application of the sunscreen 2-ethyl-hexyl-p-methoxycinnamate. J. Toxicol. - Cut. & Ocular Toxicol. 8, 209-226.
11. FREEDMAN, L. S., MIDTHUNE, D. N., BROWN, C. C., STEELE, V., and KELLOFF, G. J., 1993: Statistical analysis of animal cancer chemoprevention experiments. Biometrics 49, 259-268.
12. GART, J. J., KREWSKI, D., LEE, P. N., TARONE, R. E., and WAHRENDORF, J., 1986: Statistical Methods in Cancer Research, Volume III. The Design and Analysis of Long-term Animal Experiments. International Agency for Research on Cancer: Lyon.
13. GRUBBS, C. J., ETO, I. JULIANA, M. M., and WHITAKER, L. M., 1991: Effect of canthaxanthin on chemically induced mammary carcinogenesis. Oncology 48, 239-245.
14. HSU, CHUANCHIEH, 1995: Contributions to statistical models for the mammary cancer chemoprevention experiments. Ph.D. Dissertation, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL.
15. JOHNSON, N. L. and KOTZ, S., 1969: Discrete Distributions. New York: Wiley, 328 pp.
16. KODELL, R. L. and AHN, H., 1997: An age-adjusted trend test for the tumor incidence rate. Biometrics 53, 1467-1474.
17. KOKOSKA, S. M., 1987: The analysis of cancer chemoprevention experiments. Biometrics 43, 525-534.
18. KOKOSKA, S. M., HARDIN, J. M., GRUBBS, C. J., and HSU, C., 1993: The statistical analysis of cancer inhibition/promotion experiments. Anticancer Research 13, 1357-1364.
19. LAGAKOS, S. W., 1982: An evaluation of some two-sample tests used to analyze animal carcinogenicity experiments. Utilitas Mathematica 21B, 239-260.
20. NTP (National Toxicology Program) 1984: Report of the Ad Hoc Panel on Chemical Carcinogenesis Testing and Evaluation. Board of Scientific Counselors, National Toxicology Program, Research Triangle Park, NC.
21. PETO, R., PIKE, M. C., DAY, N. E., GRAY, R. G., LEE, P. N., PARISH, S., PETO, J., RICHARDS, S., and WAHRENDORF, J., 1980: Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. Annex to: Long-term and Short-term Screening Assays for Carcinogens: a Critical Appraisal. IARC Monographs, Supplement 2, 311-426. International Agency for Research on Cancer: Lyon.
22. TENNANT, R. W., FRENCH, J. E., and SPALDING, J. W., 1995: Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environmental Health Perspectives 103, 942-950.
23. THOMPSON, H. F., GRUBBS, C. J., MOON, R. C., and SPORN, M. B., 1978: Continual requirement of retinoid for maintenance of mammary cancer inhibition. Proceedings of the Annual Meeting of the American Association for Cancer Research 19, 74.
24. TREMPUS, C. S., HASEMAN, J. K., and TENNANT, R. W., 1997: Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2. Molecular Carcinogenesis 20, 68-77.